Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process
Med Phys
.
2011 Dec;38(12):6347-50.
doi: 10.1118/1.3639137.
Authors
David J Carlson
1
,
Kamil M Yenice
,
Colin G Orton
Affiliation
1
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA. david.j.carlson@yale.edu
PMID:
22149817
DOI:
10.1118/1.3639137
No abstract available
MeSH terms
Dose Fractionation, Radiation*
Humans
Models, Biological*
Neoplasms / physiopathology*
Neoplasms / radiotherapy*
Radiation Tolerance*
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted / methods*